Abstract:OBJECTIVES: The aim of this study was to determine the effect of different durations of menopause at the time of bone mineral density (BMD) measurement and of different age at menopause intervals on the prevalence of osteopenia and osteoporosis among untreated postmenopausal women. We also assessed related factors leading to low BMD.METHODS: A total of 2769 postmenopausal women who had not taken any anti-osteoporosis treatment and/or hormone replacement therapy were divided into three groups according to duration of menopause at the time of BMD measurement. The women were also evaluated in four different age groups according to their age at menopause onset. Multinomial logistic regression analysis was used to determine related factors leading to low BMD. Investigated parameters include demographic characteristics, plasma glucose, lipids, and lipoproteins.RESULTS: According to World Health Organization (WHO) criteria, among 2769 patients, 449 (16.2%) were identified as having osteoporosis, 1085 (39.2%) as having osteopenia, and 1235 (44.6%) as having normal BMD. Osteoporosis was determined in 10.6% and 16.2% of women with menopause duration of 0-3 years and 4-7 years, respectively, whereas this rate was 31.9% in women with menopause duration of over 7 years (p = 0.001). The percentages for osteopenia remained constant among the three different menopause durations (0-3 years: 37.2%, 4-7 years: 42.1%, and >7 years: 40.9%). Thirty percent of women with age at onset of <40 years were osteoporotic. However, the percentages of women with osteoporosis among the other age groups were similar (40-46 years: 18.3%, 47-52 years: 14.1%, and >52 years: 15.4%). The percentages for osteopenia remained relatively constant among the four age groups (36.7, 40, 39.1 and 39%). According to the multinomial logistic regression analysis, duration of menopause at the time of BMD test and parity were positively correlated with both osteoporosis and osteopenia, while glucose level was negatively correlated with both osteoporosis and osteopenia. Age at menopause was negatively correlated only for osteoporosis. Low-density lipoprotein cholesterol (LDL-c) level may be accepted as a clinically significant factor for osteopenia (OR: 1.01; CI(95%): 1.00-1.02). No differences were determined in the prevalence of osteopenia and osteoporosis in women with menopause duration of >7 years when evaluated according to the four menopause age groups as described before (p = 0.74). Contribution to the regression model was 0.8% by age at menopause, 5.6% by menopause duration at time of BMD measurement, 5.8% by both factors.CONCLUSION: According to our results, osteoporosis is related more to the duration of menopause at the time of BMD measurement rather than the age at menopause among untreated postmenopausal women. High parity was determined as another risk factor for low BMD.

Ovarian aging and bone metabolism in menstruating women aged 35-50 years

Relationship of Age-related Levels of Serum Sex Hormones with Bone Metabolism Markers in Women

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

Relationship between blood pressure levels and bone mineral density in postmenopausal Turkish women

Adult Premenopausal Bone Health Related to Reproductive Characteristics-Population-Based Data from the Canadian Multicentre Osteoporosis Study (CaM os)

Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected]

The impact of reproductive and menstrual history on bone mineral density in Chinese women.

Identification of the risk factors for osteoporosis among postmenopausal women

Increase in Cytokine Production (IL-1 Beta, IL-6, TNF-alpha but Not IFN-gamma, GM-CSF or LIF) by Stimulated Whole Blood Cells in Postmenopausal Osteoporosis.

[Investigation on Bone Health Conditions in 1637 Aged Women].

Relationship between Estradiol and Bone Biomarkers in the Longevity Females

Ovarian Aging and Osteoporosis.

Association Between Serum Oxytocin, Bone Mineral Density and Body Composition in Chinese Adult Females.

MULTIDIRECTIONAL ASSESSMENT OF BONE STRUCTURE INCLUDING RADIOISOTOPIC ANALYSIS IN PERIMENOPAUSAL WOMEN

Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity

Relationship between bone mineral density and ovarian function and thyroid function in perimenopausal women with endometriosis: a prospective study

Circulatory Levels of RANKL, OPG, and Oxidative Stress Markers in Postmenopausal Women With Normal or Low Bone Mineral Density

Menopausal bone loss is partially regulated by dietary intake of vitamin D

Lipid profile and plasma atherogenic index in postmenopausal osteoporosis

Associations of AMH in mid-reproductive years with bone mineral density and turnover markers in mid-life

Systemic Inflammation Markers Associated with Bone Mineral Density in Perimenopausal and Postmenopausal Women